Pharvaris N.V.
PHVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001830487
In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 20 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.23B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q2 2025
Institutional positions in Pharvaris N.V. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 60
- +8 vs. Q1 2025
- Shares held
- 45.0M
- +101.1K (+0.2%) vs. Q1 2025
- Total value
- $792.7M
- +$87.2M (+12.4%) vs. Q1 2025
- New holders
- 9
- 19 more added
- Sold out
- 1
- 16 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PHVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 125 | $2.23B |
| Q1 2026 | 110 | $1.67B |
| Q4 2025 | 106 | $1.64B |
| Q3 2025 | 83 | $1.44B |
| Q2 2025 | 60 | $792.7M |
| Q1 2025 | 52 | $705.5M |
| Q4 2024 | 54 | $855.8M |
| Q3 2024 | 51 | $834.2M |
| Q2 2024 | 36 | $808.6M |
| Q1 2024 | 35 | $980.5M |
| Q4 2023 | 36 | $1.14B |
| Q3 2023 | 21 | $606.6M |
| Q2 2023 | 21 | $441.6M |
| Q1 2023 | 21 | $173.9M |
| Q4 2022 | 25 | $239.6M |
| Q3 2022 | 21 | $173.6M |
| Q2 2022 | 20 | $494.0M |
| Q1 2022 | 22 | $397.1M |
| Q4 2021 | 22 | $321.1M |
| Q3 2021 | 25 | $380.3M |
| Q2 2021 | 28 | $406.3M |
| Q1 2021 | 33 | $616.5M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Pharvaris N.V.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 1 | $18 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 58 | $1.00K | 0.00% | +58 | New |
| Centerpoint Advisors, LLC | 100 | $2.00K | 0.00% | +100 | New |
| BNP Paribas Arbitrage, SA | 359 | $6.32K | 0.00% | +201+127.2% | Added |
| Point72 Asia (Singapore) Pte. Ltd. | 369 | $6.49K | 0.00% | +369 | New |
| Citigroup Inc | 557 | $9.80K | 0.00% | +14+2.6% | Added |
| Wells Fargo & Company | 1,000 | $17.6K | 0.00% | +50+5.3% | Added |
| Police & Firemen's Retirement System of New Jersey | 2,369 | $41.7K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 2,561 | $45.1K | 0.00% | +283+12.4% | Added |
| Barclays PLC | 2,796 | $49.2K | 0.00% | −65−2.3% | Reduced |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 3,261 | $57.0K | 0.00% | +3,261 | New |
| JPMorgan Chase & Co | 3,342 | $58.8K | 0.00% | +783+30.6% | Added |
| UBS Group AG | 3,743 | $65.9K | 0.00% | −3,706−49.8% | Reduced |
| Public Employees Retirement System of Ohio | 4,500 | $79.2K | 0.00% | 00.0% | Unchanged |
| Virtus Investment Advisers, Inc. | 5,457 | $96.0K | 0.03% | −3,179−36.8% | Reduced |
| KLP Kapitalforvaltning AS | 5,800 | $102.1K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 11,550 | $203.3K | 0.00% | +1,695+17.2% | Added |
| Millennium Management LLC | 13,285 | $233.8K | 0.00% | +13,285 | New |
| California State Teachers Retirement System | 14,048 | $247.2K | 0.00% | +1,257+9.8% | Added |
| Palumbo Wealth Management LLC | 14,549 | $256.1K | 0.08% | +447+3.2% | Added |
| Bank of America Corp | 16,023 | $282.0K | 0.00% | −13,183−45.1% | Reduced |
| Boothbay Fund Management, LLC | 16,187 | $284.9K | 0.01% | +16,187 | New |
| HighVista Strategies LLC | 23,739 | $417.8K | 0.15% | +971+4.3% | Added |
| Swiss National Bank | 26,257 | $462.1K | 0.00% | 00.0% | Unchanged |
| Amundi | 27,417 | $488.6K | 0.00% | +27,416+2,741,600.0% | Added |
| Deutsche Bank AG | 28,186 | $496.1K | 0.00% | +120.0% | Added |
| Citadel Advisors LLC | 29,221 | $514.3K | 0.00% | +29,221 | New |
| Alps Advisors Inc | 29,398 | $517.4K | 0.00% | −7,235−19.7% | Reduced |
| ADAR1 Capital Management, LLC | 34,124 | $600.6K | 0.10% | +34,124 | New |
| Point72 Asset Management, L.P. | 37,612 | $662.0K | 0.00% | −14,962−28.5% | Reduced |
| Manufacturers Life Insurance Company, The | 48,857 | $859.9K | 0.00% | +7,879+19.2% | Added |
| Geode Capital Management, LLC | 54,102 | $951.9K | 0.00% | +15,769+41.1% | Added |
| UBS Asset Management Americas Inc | 55,377 | $974.6K | 0.00% | −12,954−19.0% | Reduced |
| Morgan Stanley | 59,772 | $1.05M | 0.00% | −15,593−20.7% | Reduced |
| State Street Corp | 93,673 | $1.65M | 0.00% | −111−0.1% | Reduced |
| Northern Trust Corp | 95,269 | $1.68M | 0.00% | +8,393+9.7% | Added |
| TD Asset Management Inc | 99,510 | $1.75M | 0.00% | +21,388+27.4% | Added |
| Polygon Management Ltd. | 188,100 | $3.31M | 0.60% | +61,105+48.1% | Added |
| BlackRock, Inc. | 201,089 | $3.54M | 0.00% | +8,224+4.3% | Added |
| Rosalind Advisors, Inc. | 223,627 | $3.94M | 1.90% | 00.0% | Unchanged |
| Patient Square Capital LP | 244,283 | $4.30M | 1.55% | −1,213−0.5% | Reduced |
| Sphera Funds Management Ltd. | 309,931 | $5.45M | 1.43% | −73,925−19.3% | Reduced |
| Sofinnova Investments, Inc. | 585,532 | $10.3M | 0.70% | −7,871−1.3% | Reduced |
| Rock Springs Capital Management LP | 623,402 | $11.0M | 0.68% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 672,595 | $11.8M | 2.60% | −97,220−12.6% | Reduced |
| Soleus Capital Management, L.P. | 732,968 | $12.9M | 0.89% | −81,684−10.0% | Reduced |
| Price T Rowe Associates Inc | 767,315 | $13.5M | 0.00% | +181,228+30.9% | Added |
| 5AM Venture Management, LLC | 797,600 | $14.0M | 5.40% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 1,062,911 | $18.7M | 0.80% | +1,062,911 | New |
| Cormorant Asset Management, LP | 1,454,660 | $25.6M | 1.91% | −11,800−0.8% | Reduced |
| Novo Holdings A/S | 1,725,000 | $30.4M | 2.14% | 00.0% | Unchanged |
| Commodore Capital LP | 1,911,433 | $33.6M | 2.37% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 2,017,464 | $35.5M | 0.64% | 00.0% | Unchanged |
| VR Adviser, LLC | 2,047,620 | $36.0M | 2.70% | −1,065,100−34.2% | Reduced |
| Bain Capital Life Sciences Investors, LLC | 3,303,381 | $58.1M | 7.27% | 00.0% | Unchanged |
| Viking Global Investors LPSuperinvestorViking Global Investors | 3,653,310 | $64.3M | 0.19% | 00.0% | Unchanged |
| venBio Partners LLC | 4,289,304 | $75.5M | 65.78% | 00.0% | Unchanged |
| Foresite Capital Management IV, LLC | 4,410,581 | $77.6M | 62.70% | 00.0% | Unchanged |
| FMR LLC | 5,422,393 | $95.4M | 0.01% | +27,023+0.5% | Added |
| General Atlantic LLC | 7,531,252 | $132.6M | 3.65% | 00.0% | Unchanged |
| Vanguard Group Inc | 0 | $0 | 0.00% | −12,740−100.0% | Sold out |